Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HCAR2 | Q8TDS4 | 13/20 | 0.59 |
| ▸ | DAO | P14920 | 1/20 | 0.59 |
| ▸ | HCAR3 | P49019 | 2/20 | 0.53 |
| ▸ | CYTH3 | O43739 | 1/20 | 0.53 |
| ▸ | BTK | Q06187 | 1/20 | 0.53 |
| ▸ | EPN1 | Q9Y6I3 | 1/20 | 0.53 |
| ▸ | ALPL | P05186 | 4/20 | 0.53 |
| ▸ | CA12 | O43570 | 2/20 | 0.53 |
| ▸ | TP53 | P04637 | 1/20 | 0.52 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19987833 | 0.98 | HCAR2 (0.57) | HCAR2DAOHCAR3CYTH3BTK | |
| SCHEMBL28638090 | 0.98 | HCAR2 (0.57) | HCAR2DAOHCAR3CYTH3BTK | |
| Hydrochloric Acid SCHEMBL7723258 | 0.98 | HCAR2 (0.57) | HCAR2DAOHCAR3CYTH3BTK | |
| Hydrochloric Acid SCHEMBL11595364 | 0.98 | HCAR2 (0.57) | HCAR2DAOHCAR3CYTH3BTK | |
| Water SCHEMBL1267709 | 0.98 | HCAR2 (0.57) | HCAR2DAOHCAR3CYTH3BTK | |
| Ammonia Solution, Strong SCHEMBL28463590 | 0.96 | HCAR2 (0.55) | HCAR2DAOHCAR3CYTH3BTK | |
| SCHEMBL5599765 | 0.85 | HCAR2 (0.53) | HCAR2DAOHCAR3CYTH3BTK | |
| SCHEMBL12168148 | 0.85 | HCAR2 (0.59) | HCAR2DAOHCAR3CYTH3BTK | |
| SCHEMBL8068032 | 0.85 | TP53 (0.47) | HCAR2DAOHCAR3CYTH3BTK | |
| SCHEMBL12943881 | 0.85 | TP53 (0.47) | HCAR2DAOHCAR3CYTH3BTK |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1838 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260131307-A1 | Bi-Metallic Pillared-Layered Coordination Polymers for Carbon Dioxide Removal | UNIV OF PUERTO RICO (US) | 2026-05-14 | — | — | US | claimed |
| CN-122006606-A | Preparation method of aluminum-based MOF nanofiber aerogel | 东华大学 | 2026-05-12 | — | — | CN | claimed |
| WO-2026047173-A1 | PROCESS FOR PREPARING SUSTAINABLE JET FUELS OR DIESEL FUELS; AND PRECURSORS THEREOF | Terra Mater BV (BE) | 2026-03-05 | — | — | WO | claimed |
| US-20260042084-A1 | SORBENTS FUNCTIONALIZED WITH LIGANDS HAVING AN AMINOSILICONE FUNCTIONAL GROUP | GENERAL ELECTRIC TECHNOLOGY GMBH (CH) | 2026-02-12 | — | — | US | claimed |
| EP-4680369-A1 | SYSTEMS FOR CARBON DIOXIDE CAPTURE USING FUNCTIONALIZED SORBENTS AND WATER MANAGEMENT | GE Vernova Technology GmbH (CH) | 2026-01-21 | — | — | EP | claimed |
| US-12515195-B2 | Bi-metallic pillared-layered coordination polymers for carbon dioxide removal | UNIVERSITY OF PUERTO RICO | 2026-01-06 | — | — | US | claimed |
| EP-4622945-A1 | OLIGOMERISATION OF ALCOHOLS | Terra Mater BV (BE) | 2025-10-01 | — | — | EP | claimed |
| EP-4572884-A1 | SORBENTS FUNCTIONALIZED WITH LIGANDS HAVING AN AMINOSILICONE FUNCTIONAL GROUP | General Electric Technology GmbH (CH) | 2025-06-25 | — | — | EP | claimed |
| US-20250170554-A1 | HYDROPHOBIC METAL ORGANIC FRAMEWORK MATERIAL | METAL INDUSTRIES RESEARCH & DEVELOPMENT CENTRE (TW) | 2025-05-29 | — | — | US | claimed |
| CN-120028253-A | Formic acid concentration detection optical fiber sensor and detection method | 重庆理工大学 | 2025-05-23 | — | — | CN | claimed |
| US-20020177196-A1 | Process for preparing non-proteinogenic L-amino acids | CONSORTIUM FUR ELEKTROCHEMISCHE INDUSTRIE GMBH | 2002-11-28 | — | — | US | claimed |
| WO-2002088219-A1 | PROTON-CONDUCTING MEMBRANE AND USE THEREOF | CELANESE VENTURES GMBH (DE) | 2002-11-07 | — | — | WO | claimed |
| WO-2002081547-A1 | PROTON-CONDUCTING MEMBRANE AND THE USE THEREOF | CELANESE VENTURES GMBH (DE) | 2002-10-17 | — | — | WO | claimed |
| EP-1247869-A1 | Process for the production of non-proteinogenic amino acids | Consortium für elektrochemische Industrie GmbH (DE) | 2002-10-09 | — | — | EP | claimed |
| EP-0673783-B1 | Recording sheets containing purine, pyrimidine, benzimidazole, imidazolidine, urazole, pyrazole, triazole, benzotriazole, tetrazole, and pyrazine compounds | XEROX CORP (US) | 2000-07-05 | — | — | EP | claimed |
| US-5659348-A | APPLYING TO A SUBSTRATE | XEROX CORPORATION (US) | 1997-08-19 | — | — | US | claimed |
| EP-0673783-A2 | Recording sheets containing purine, pyrimidine, benzimidazole, imidazolidine, urazole, pyrazole, triazole, benzotriazole, tetrazole, and pyrazine compounds | XEROX CORPORATION (US) | 1995-09-27 | — | — | EP | claimed |
| EP-0145506-B1 | ELIMINATION OF DEFECTS IN CYSTEINE-SENSITIZED EMULSIONS | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 1988-03-02 | — | — | EP | claimed |
| EP-0145506-A2 | Elimination of defects in cysteine-sensitized emulsions | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 1985-06-19 | — | — | EP | claimed |
| US-4514492-A | Elimination of defects in cysteine-sensitized emulsions | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 1985-04-30 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260042084-A1 | SORBENTS FUNCTIONALIZED WITH LIGANDS HAVING AN AMINOSILICONE FUNCTIONAL GROUP | SRMS, TYRO3, SELE | HCAR2 2304/4885DAO 229/4885HCAR3 3140/4885 |
| US-20260131307-A1 | Bi-Metallic Pillared-Layered Coordination Polymers for Carbon Dioxide Removal | MAP2K4, MAP2K1, MAP2K2 | HCAR2 2102/4885DAO 2668/4885HCAR3 3648/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.